Arterial thromboembolism and acute coronary syndrome in patients with malignant diseases. Analytical review. Part 1

Arterial thromboembolic complications are rare in cancer patients. Malignant neoplasms and antitumor therapy contribute to an increased risk of arterial thromboembolism, ischemic stroke, and myocardial infarction. The development of arterial thromboembolism in people without a history of cancer may be a harbinger of as yet undetected malignancies. Understanding the process of arterial thromboembolism is an important prerequisite for the proper management of patients with cancer during and after treatment in order to prevent life-threatening complications.